EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan

Chung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, Chih-Wen Wang, Tyng-Yuan Jang, Po-Cheng Liang, Tzu-Chun Lin, Pei-Chien Tsai, Yu-Ju Wei, Ming-Lun Yeh, Ming-Yen Hsieh, Chao-Kuan Huang und 3 weitere

Clinical and Molecular Hepatology · 2024

DOI: 10.3350/cmh.2024.0414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, 2024. Verfasst von Chung-Feng Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and …. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Antiviral Agents, Registries, Fatty Liver. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Kaohsiung Medical University, Kaohsiung Medical University Hospital, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Steatotic liver disease (SLD) is a common manifestation in chronic hepatitis C (CHC). Metabolic alterations in CHC are associated with metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to elucidate whether hepatitis C virus (HCV) eradication mitigates MASLD occurrence or resolution.

Methods

We enrolled 5,840 CHC patients whose HCV was eradicated by direct-acting antivirals in a nationwide HCV registry. MASLD and the associated cardiometabolic risk factors (CMRFs) were evaluated at baseline and 6 months after HCV cure.

Results

There were 2,147 (36.8%) patients with SLD, and 1,986 (34.0%) of them met the MASLD criteria before treatment. After treatment, HbA1c (6.0% vs. 5.9%, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicAntiviral AgentsRegistriesFatty LiverHepacivirusHumansMaleFemaleMiddle AgedTaiwanRisk FactorsAdultAgedGlycated HemoglobinBody Mass IndexTriglycerides

Stichwörter der Autor:innen

CMRFHCVMASLDSLDSVR

Substanzen

Antiviral AgentsGlycated HemoglobinTriglycerideshemoglobin A1c protein, human

Autor:innen und Institutionen

  • Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University and Academia Sinica, Kaohsiung, Taiwan.
  • Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwa…

Förderung

  • Kaohsiung Medical University
  • Kaohsiung Medical University Hospital
  • Ministry of Health and Welfare
  • Ministry of Education

Zitieren

APA

Huang, C. F., Dai, C. Y., Lin, Y. H., Wang, C. W., Jang, T. Y., Liang, P. C., Lin, T. C., Tsai, P. C., Wei, Y. J., Yeh, M. L., Hsieh, M. Y., Huang, C. K., Huang, J. F., Chuang, W. L., & Yu, M. L. (2024). Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2024.0414

Vancouver

Huang CF, Dai CY, Lin YH, Wang CW, Jang TY, Liang PC, et al. Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan. Clinical and Molecular Hepatology. 2024. doi:10.3350/cmh.2024.0414

BibTeX
@article{Huang2024,
  author = {Huang, Chung-Feng and Dai, Chia-Yen and Lin, Yi-Hung and Wang, Chih-Wen and Jang, Tyng-Yuan and Liang, Po-Cheng and Lin, Tzu-Chun and Tsai, Pei-Chien and Wei, Yu-Ju and Yeh, Ming-Lun and Hsieh, Ming-Yen and Huang, Chao-Kuan and Huang, Jee-Fu and Chuang, Wan-Long and Yu, Ming-Lung},
  title = {Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  doi = {10.3350/cmh.2024.0414}
}
Kostenlos starten →